Orthopaedic manifestations of neurofibromatosis type 1

Journal of the American Academy of Orthopaedic Surgeons

Volumn 18, Issue 6, 2010, Pages 346-357

  Feldman, David S ^a   Jordan, Charles ^a   Fonseca, Lauren ^a  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953547628     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-201006000-00007     Document Type: Review

References (63)

1. Friedman JM: Epidemiology of neurofibromatosis type 1. Am J Med Genet 1999; 89(1): 1-6.
2. von Recklinghausen FD: Ueber die multiplen fibrome der Hautund inhre beziehung zu den multiplen neuromen. Berlin, Germany, Hirschwald, 1882.
3. Li Y, O'Connell P, Breidenbach HH, et al: Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995; 25(1): 9-18.
4. DeClue JE, Cohen BD, Lowy DR: Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci U S A 1991; 88(22): 9914-9918. (Pubitemid 21915745)
5. Gutmann DH, Wood DL, Collins FS: Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 1991; 88(21): 9658-9662. (Pubitemid 21915690)
6. Upadhyaya M, Roberts SH, Maynard J, et al: A cytogenetic deletion, del(17) (q11.22q21.1), in a patient with sporadic neurofibromatosis type 1 (NF1) associated with dysmorphism and developmental delay. J Med Genet 1996; 33(2): 148-152. (Pubitemid 26055747)
7. Xu GF, O'Connell P, Viskochil D, et al: The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990; 62(3): 599-608. (Pubitemid 20263229)
8. Daston MM, Scrable H, Nordlund M, Sturbaum AK, Nissen LM, Ratner N: The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes. Neuron 1992; 8(3): 415-428.
9. Kolanczyk M, Kossler N, Kühnisch J, et al: Multiple roles for neurofibromin in skeletal development and growth. Hum Mol Genet 2007; 16(8): 874-886. (Pubitemid 47062733)
10. National Institutes of Health Consensus Development Conference Statement: Neurofibromatosis. Bethesda, Md., USA, July 13-15, 1987. Neurofibromatosis 1988; 1(3): 172-178.
11. DeBella K, Szudek J, Friedman JM: Use J of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics 2000; 105(3 pt 1): 608-614. (Pubitemid 30129679)
12. Wolkenstein P, Durand-Zaleski I, Moreno JC, Zeller J, Hemery F, Revuz J: Cost evaluation of the medical management of neurofibromatosis 1: A prospective study on 201 patients. Br J Dermatol 2000; 142(6): 1166-1170. (Pubitemid 30418304)
13. Thiagalingam S, Flaherty M, Billson F, North K: Neurofibromatosis type 1 and optic pathway gliomas: Follow-up of 54 patients. Ophthalmology 2004; 111(3): 568-577. (Pubitemid 38293118)
14. Lim R, Jaramillo D, Poussaint TY, Chang Y, Korf B: Superficial neurofibroma: A lesion with unique MRI characteristics in patients with neurofibromatosis type 1. AJR Am J Roentgenol 2005; 184(3): 962-968. (Pubitemid 43899529)
15. Ferner RE, Gutmann DH: International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 2002; 62(5): 1573-1577. (Pubitemid 34407825)
16. Trovó-Marqui AB, Goloni-Bertollo EM, Valério NI, et al: High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1. Braz J Med Biol Res 2005; 38(9): 1441-1447.
17. Blitman NM, Levsky JM, VillanuevaSiles E, Thornhill BA: Spontaneous hemorrhage simulating rapid growth of a benign subperiosteal plexiform neurofibroma. Pediatr Radiol 2007; 37(9): 925-928.
18. Waggoner DJ, Towbin J, Gottesman G, Gutmann DH: Clinic-based study of plexiform neurofibromas in neurofibromatosis 1. Am J Med Genet 2000; 92(2): 132-135. (Pubitemid 30256441)
19. Altinova AE, Toruner F, Cimen AR, et al: The association of neurofibromatosis, bilateral pheochromocytoma and primary hyperparathyroidism. Exp Clin Endocrinol Diabetes 2007; 115(7): 468-470. (Pubitemid 47234649)
20. Valeyrie-Allanore L, Ortonne N, Lantieri L, et al: Histopathologically dysplastic neurofibromas in neurofibromatosis 1: Diagnostic criteria, prevalence and clinical significance. Br J Dermatol 2008; 158(5): 1008-1012. (Pubitemid 351521455)
21. Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A: Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 2002; 39(5): 311-314. (Pubitemid 34526349)
22. Bilgic B, Ates LE, Demiryont M, Ozger H, Dizdar Y: Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. Pathol Oncol Res 2003; 9(3): 201-205.
23. Ferner RE, Golding JF, Smith M, et al: [ 18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): A long-term clinical study. Ann Oncol 2008; 19(2): 390-394.
24. Perry A, Roth KA, Banerjee R, Fuller CE, Gutmann DH: NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1 (-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am J Pathol 2001; 159(1): 57-61.
25. Krab LC, Aarsen FK, de Goede-Bolder A, et al: Impact of neurofibromatosis type 1 on school performance. J Child Neurol 2008; 23(9): 1002-1010.
26. Belzeaux R, Lançon C: Neurofibromatosis type 1: Psychiatric disorders and quality of life impairment [French]. Presse Med 2006; 35(2 pt 2): 277-280.
27. Kraut MA, Gerring JP, Cooper KL, Thompson RE, Denckla MB, Kaufmann WE: Longitudinal evolution of unidentified bright objects in children with neurofibromatosis-1. Am J Med Genet A 2004; 129A(2): 113-119.
28. Gutmann DH, Aylsworth A, Carey JC, et al: The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 1997; 278(1): 51-57.
29. Abdel-Wanis ME, Kawahara N: Aetiology of spinal deformities in neurofibromatosis 1: New hypotheses. Med Hypotheses 2001; 56(3): 400-404.
30. Durrani AA, Crawford AH, Chouhdry SN, Saifuddin A, Morley TR: Modulation of spinal deformities in patients with neurofibromatosis type 1. Spine (Phila Pa 1976) 2000; 25(1): 69-75.
31. Tsirikos AI, Ramachandran M, Lee J, Saifuddin A: Assessment of vertebral scalloping in neurofibromatosis type 1 with plain radiography and MRI. Clin Radiol 2004; 59(11): 1009-1017.
32. Ramachandran M, Tsirikos AI, Lee J, Saifuddin A: Whole-spine magnetic resonance imaging in patients with neurofibromatosis type 1 and spinal deformity. J Spinal Disord Tech 2004; 17(6): 483-491.
33. Li M, Fang X, Li Y, Ni J, Gu S, Zhu X: Successful use of posterior instrumented spinal fusion alone for scoliosis in 19 patients with neurofibromatosis type-1 followed up for at least 25 months. Arch Orthop Trauma Surg 2009; 129(7): 915-921.
34. Halmai V, Doman I, de Jonge T, Ules T: Surgical treatment of spinal deformities associated with neurofibromatosis type 1: Report of 12 cases. J Neurosurg 2002; 97(3 suppl): 310-316.
35. Parisini P, Di Silvestre M, Greggi T, Paderni S, Cervellati S, Savini R: Surgical correction of dystrophic spinal curves in neurofibromatosis: A review of 56 patients. Spine (Phila Pa 1976) 1999; 24(21): 2247-2253.
36. Singh K, Samartzis D, An HS: Neurofibromatosis type I with severe dystrophic kyphoscoliosis and its operative management via a simultaneous anterior-posterior approach: A case report and review of the literature. Spine J 2005; 5(4): 461-466.
37. Kumar K, Crawford AH: Role of "Bovie" in spinal surgery: Historical and analytical perspective. Spine (Phila Pa 1976) 2002; 27(9): 1000-1006.
38. Torpey BM, Dormans JP, Drummond DS: The use of MRI-compatible titanium segmental spinal instrumentation in pediatric patients with intraspinal tumor. J Spinal Disord 1995; 8(1): 76-81.
39. Winter RB, Lonstein JE, Anderson M: Neurofibromatosis hyperkyphosis: A review of 33 patients with kyphosis of 80 degrees or greater. J Spinal Disord 1988; 1(1): 39-49.
40. Yong-Hing K, Kalamchi A, MacEwen GD: Cervical spine abnormalities in neurofibromatosis. J Bone Joint Surg Am 1979; 61(5): 695-699.
41. Goffin J, Grob D: Spondyloptosis of the cervical spine in neurofibromatosis: A case report. Spine (Phila Pa 1976) 1999; 24(6): 587-590.
42. Craig JB, Govender S: Neurofibromatosis of the cervical spine: A report of eight cases. J Bone Joint Surg Br 1992; 74(4): 575-578.
43. Toyoda K, Taguchi T, Kaneko K, Kato Y, Imajo Y, Imagama T: High-grade L5 spondylolisthesis associated with dural ectasia in neurofibromatosis. J Orthop Sci 2005; 10(2): 233-236.
44. Sulaiman AR, Nordin S, Faisham WI, Zulmi W, Halim AS: Residual nonunion following vascularized fibular graft treatment for congenital pseudarthrosis of the tibia: A report of two cases. J Orthop Surg (Hong Kong) 2006; 14(1): 64-66.
45. Gilbert A, Brockman R: Congenital pseudarthrosis of the tibia: Long-term followup of 29 cases treated by microvascular bone transfer. Clin Orthop Relat Res 1995; 314: 37-44.
46. Friedman JM, Birch PH: Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 1997; 70(2): 138-143.
47. Stevenson DA, Birch PH, Friedman JM, et al: Descriptive analysis of tibial pseudarthrosis in patients with neurofibromatosis 1. Am J Med Genet 1999; 84(5): 413-419.
48. Sakamoto A, Yoshida T, Yamamoto H, Oda Y, Tsuneyoshi M, Iwamoto Y: Congenital pseudarthrosis of the tibia: Analysis of the histology and the NF1 gene. J Orthop Sci 2007; 12(4): 361-365.
49. Wright J, Dormans J, Rang M: Pseudarthrosis of the rabbit tibia: A model for congenital pseudarthrosis? J Pediatr Orthop 1991; 11(3): 277-283.
50. Vander Have KL, Hensinger RN, Caird M, Johnston C, Farley FA: Congenital pseudarthrosis of the tibia. J Am Acad Orthop Surg 2008; 16(4): 228-236.
51. Johnston CE II: Congenital pseudarthrosis of the tibia: Results of technical variations in the charnley-williams procedure. J Bone Joint Surg Am 2002; 84(10): 1799-1810.
52. Ohnishi I, Sato W, Matsuyama J, et al: Treatment of congenital pseudarthrosis of the tibia: A multicenter study in Japan. J Pediatr Orthop 2005; 25(2): 219-224.
53. Weiland AJ, Weiss AP, Moore JR, Tolo VT: Vascularized fibular grafts in the treatment of congenital pseudarthrosis of the tibia. J Bone Joint Surg Am 1990; 72(5): 654-662.
54. Lehman WB, Atar D, Feldman DS, Gordon JC, Grant AD: Congenital pseudoarthrosis of the tibia. J Pediatr Orthop B 2000; 9(2): 103-107.
55. Dobbs MB, Rich MM, Gordon JE, Szymanski DA, Schoenecker PL: Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia: A long-term follow-up study. J Bone Joint Surg Am 2004; 86(6): 1186-1197.
56. Paley D, Catagni M, Argnani F, Prevot J, Bell D, Armstrong P: Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique. Clin Orthop Relat Res 1992; 280: 81-93.
57. Ofluoglu O, Davidson RS, Dormans JP: Prophylactic bypass grafting and longterm bracing in the management of anterolateral bowing of the tibia and neurofibromatosis-1. J Bone Joint Surg Am 2008; 90(10): 2126-2134.
58. Richards BS, Oetgen ME, Johnston CE: The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: A case series. J Bone Joint Surg Am 2010; 92(1): 177-185.
59. Inan M, El Rassi G, Riddle EC, Kumar SJ: Residual deformities following successful initial bone union in congenital pseudoarthrosis of the tibia. J Pediatr Orthop 2006; 26(3): 393-399.
60. Alwan S, Tredwell SJ, Friedman JM: Is osseous dysplasia a primary feature of neurofibromatosis 1 (NF1)? Clin Genet 2005; 67(5): 378-390.
61. Brunetti-Pierri N, Doty SB, Hicks J, et al: Generalized metabolic bone disease in neurofibromatosis type I. Mol Genet Metab 2008; 94(1): 105-111.
62. Herrera-Soto JA, Crawford AH, Loveless EA: Ossifying subperiosteal hematoma associated with neurofibromatosis type 1: Diagnostic hesitation. A case report and literature review. J Pediatr Orthop B 2005; 14(1): 51-54.
63. Szudek J, Birch P, Friedman JM: Growth in North American white children with neurofibromatosis 1 (NF1). J Med Genet 2000; 37(12): 933-938.